Jul 19, 2021
Helen Stevenson, Founder & CEO, Reformulary Group

Helen Stevenson, BCom, MSM, ICD.D is Founder and CEO of Reformulary Group Inc., a healthcare company that built a proprietary evidence-based drug list, the Reformulary®, and award-winning DrugFinder™ tool that provides Canadians with valuable, comparative drug information and saves money for company health benefit plans. The company recently launched Cannabis Standard™, a platform for Canadians to discover if medical cannabis might work for them, search comparable products, and track their health.

In 2018, Helen was named by MaRS Discovery District as one of eight Canadian female founders who have a relentless pursuit of success in science and tech.

Helen is the former Assistant Deputy Minister of Health and Executive Officer of Ontario Public Drug Programs, responsible for the Province’s $4 billion publicly funded drug programs.  Under her leadership, the Government achieved an unprecedented $1.5 billion in savings over five years. Prior to that Helen was Founder and President of Savattuq Inc., a healthcare consultancy in Toronto and previously in Zurich, Switzerland.

She was a founding Trustee of the Auto Sector Retiree Health Care Trust (asrTrust), as well as Chair of the Governance Committee and member of the Benefits Committee for seven years before stepping down in December 2017.

Helen holds a Bachelor of Commerce degree from McGill University, Montreal, Canada and a Master of Science in Management from Boston University Brussels. She holds the ICD.D designation. Helen has lived and worked in Canada, Belgium, and Switzerland.